Patricia Valerio, PhD,  —

Patricia holds a PhD in Neurobiology from the University of Basel, Switzerland, where she studied how hearing develops and functions. She is originally from Portugal and earned an MSc in Cellular and Molecular Biology, focusing on metabolic diseases, such as diabetes, and a BSc in Biomedical Pharmacy from the University of Coimbra. Patricia enjoys communicating science to inspire, educate and help different audiences understand its complexity and relevance.

Articles by Patricia Valerio

IRL1117, Potential Improvement on Levodopa, May Enter Clinical Trial

IRLAB Therapeutics has selected a dopamine receptor agonist candidate called IRL1117 to advance as a Parkinson’s disease treatment, potentially as a longer-lasting alternative to levodopa with lesser side effects. IRL1117 is designed to be a once-daily oral therapy for the hallmark symptoms of Parkinson’s — tremors, rigidity, and slowness of…

Your Parkinson’s Community

Woman laying down illustration

Visit the Parkinson’s News Today forums to connect with others in the Parkinson’s community.

View Forums